We observed that the treatment of pancreatic cancer cells with honokiol resulted in G1-phase arrest of cell cycle progression, along with reduction in cyclin D1, cyclin E, Cdk2 and Cdk4 and increase in p21 and p27 at the protein level. Here, CDK4 is linked to pancreatic neoplasm.